You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline

You are reading 1 of 2 free-access articles allowed for 30 days

Irish Endocrine Society 2017 Annual Meeting Preview

By Mindo - 05th Oct 2017 | 11 views

<p class=”p1″>The Irish Endocrine Society (IES) 41st Annual Meeting is due to take place in the Grand Hotel, Malahide, on 13 and 14 October. As usual, the meeting will be packed with an array of expert presentations based on cutting-edge research by national and international leaders in the field. Speaking to the <strong><em>Medical Independent</em></strong> (<strong><em>MI</em></strong>) in advance of the meeting, President of the Society and Professor of Endocrinology and Metabolism, School of Biomedical Sciences, Ulster University, Prof Finbarr O’Harte said that he is very much looking forward to this year’s gathering. 

<p class=”p3″><span class=”s1″>“It has been very exciting for me being President,” he commented. “It has been nice to see the background work that goes on in the Society to organise meetings like these. We are all looking forward to it.”</span>

<p class=”p3″><span class=”s1″>After Prof O’Harte launches proceedings on the opening day of the meeting, the first speaker will be the current President of the European Society of Endocrinology, Prof AJ van der Lely, who is also Head of the Division of Endocrinology and Professor of Endocrinology at the Erasmus University MC in Rotterdam, the Netherlands. His main research areas are pituitary diseases and the study of the role of gut hormones, such as ghrelin, which regulates appetite. Later in the day, Prof Marta Korbonits, Department of Endocrinology, William Harvey Institute, Barts and the London Medical School, Queen Mary University of London, UK, will deliver the Hadden Lecture. The title of her talk is ‘Truth in the Folktales’. </span>

<p class=”p3″><span class=”s1″>In her research Prof Korbonits has investigated the aetiology and tumourigenic process of familial and sporadic pituitary adenomas. She set up the International Familial Isolated Pituitary Adenoma (FIPA) Consortium and studies the clinical, genetic and molecular characteristics of these patients. A particular focus is the mechanism by which loss-of-function AIP mutations cause particularly aggressive adenomas at a young age, via RNA microarray studies on cell lines and human samples; establishment of animal models in mice and in the fruitfly; dissecting the regulation of AIP expression and the role of AIP in pituitary development. She has established the genetic alteration in a patient with gigantism from the 18th century and identified the current living families related to this patient.</span>

<p class=”p3″><span class=”s2″>Both Prof van der Lely and Prof Korbonitis will lead a special training session for specialist registrars. Prof O’Harte said the session, which forms part of the meeting every year, is very beneficial for younger doctors. </span>

<p class=”p3″><span class=”s1″>“I think it is great because they get a specialist with a different point of view,” he said.</span>

<p class=”p3″><span class=”s1″>“A lot of time we have had folk over from the US and Canada, from all over basically. You get a different perspective. They are usually people who are leading their field and are very highly specialised. That training is always a high point for the SpRs. They always really appreciate it, and we appreciate it too.”</span>

<p class=”p4″><strong>Irish experts</strong>

<p class=”p3″><span class=”s1″>Closer to home, Prof Aine McKillop, SAAD Centre for Pharmacy and Diabetes, School of Biomedical Sciences, Ulster University, Coleraine, will deliver the McKenna Lecture. The title of her talk is ‘GPCRS in the islets: an untapped opportunity for novel diabetic therapies’. Prof McKillop is interested in novel therapeutic targets for diabetes; the role of GPCRS in diabetes; diagnostic biomarkers for early detection of diabetes; and clinical biochemistry and diabetes proteomics.</span>

<p class=”p3″><span class=”s3″>The meeting programme also contains many shorter presentations and poster sessions as well, with a very high standard of submitted research.</span>

<p class=”p3″><span class=”s3″>“Last year in Belfast we had more abstracts than ever before, I think we had somewhere in the region of 160 abstracts,” Prof O’Harte noted.</span>

<p class=”p3″><span class=”s3″>“That was the most we ever had. We have something similar this year.  There is also a good number of people coming to the meeting. Typically we get maybe somewhere between 160 and 200 people, so I think it will be somewhere in the top end of that this time as well.”</span>

<p class=”p4″><strong>Diabetes</strong>

<p class=”p3″><span class=”s3″>Unsurprisingly, much of the submitted research deals with diabetes. Prof O’Harte attributed the rise of diabetes research to the epidemic in the condition among the international population over the past number of decades. </span>

<p class=”p3″><span class=”s3″>“I’ve been going to these meetings since 2001,” he said.</span>

<p class=”p3″><span class=”s2″>“Diabetes at that time might have only accounted for 25 per cent of the presentations and abstracts. Now diabetes seems to be 60 per cent of what is going on. It shows the incredible interest there is now in diabetes. I think partly it has to do with the fact there has been a massive increase in diabetes incidence over the last 20 years. But because it is so widespread and so common, in terms of research, it is probably easier to get funding than something like growth hormone defects or pituitary defects or thyroid defects, which is maybe more of a niche area in terms of endocrinology. So I suppose it has come to the forefront from that point of view and there has been a bit of money put in there to try and bolster diabetes research.”</span>

<p class=”p3″><span class=”s1″>The reversal of diabetes following bariatric surgery and the conversion of white adipose tissue to brown are two interesting areas of current diabetes research, he said.</span>

<p class=”p3″><span class=”s1″>Prof O’Harte, who is a research scientist himself, added that one of the “unique” elements of the Society is how membership is comprised of both clinicians and basic scientists. </span>

<p class=”p3″>“It is almost a unique society from that point of view because the basic scientist people like ourselves will get to hear about clinical things and learn about that aspect,” he explained.

<p class=”p3″><span class=”s1″>“There certainly are a good number of abstracts from basic scientists.  And the clinical people will hear about that. It does help with the cross fertilisation of ideas. We are removed ourselves from clinical studies in humans, you know. I am working on cells and mice and things like that, but I am quite removed from clinical studies in humans. So it is great for me to hear what is going on. I would say there is a lot of diabetes in the meeting but it won’t all be diabetes.  Many other endocrine disorders will be covered as well of course.”</span>

<p class=”p3″><span class=”s1″>Another benefit of the IES is that it is an all-island body. Prof O’Harte said there are currently strong research collaborations between North and South bodies. However, there is a lot of uncertainty about how Brexit will affect this research in the future. </span>

<p class=”p3″><span class=”s1″>In conclusion, Prof O’Harte said he hopes the IES meeting will be of benefit to attendees in terms of their own practice and research and that the Society continues to go from strength to strength. </span>

<p class=”p3″><span class=”s3″>“The Society has probably been thriving more than ever in terms of numbers and people going to meetings,” he stated. “It is doing well.”</span>

<p class=”p3″><span class=”s3″>There will be exclusive full coverage of the IES meeting in the 6 November issue of <strong><em>MI</em></strong>.</span>

Leave a Reply

Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read